| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study
|
Necchi, Andrea
|
|
|
4 |
6 |
p. 1001-1005
|
article
|
| 2 |
Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature
|
Green, Elizabeth A.
|
|
|
4 |
6 |
p. 893-903
|
article
|
| 3 |
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)
|
Falagario, Ugo Giovanni
|
|
|
4 |
6 |
p. 971-979
|
article
|
| 4 |
Contents
|
|
|
|
4 |
6 |
p. iii-vi
|
article
|
| 5 |
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis
|
Laukhtina, Ekaterina
|
|
|
4 |
6 |
p. 927-942
|
article
|
| 6 |
Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men
|
Russo, Filippo
|
|
|
4 |
6 |
p. 855-862
|
article
|
| 7 |
Editorial Board
|
|
|
|
4 |
6 |
p. i-ii
|
article
|
| 8 |
Epidemiology and Prevention of Prostate Cancer
|
Gandaglia, Giorgio
|
|
|
4 |
6 |
p. 877-892
|
article
|
| 9 |
Equity in Drug Accessibility: The Surprising Case of Treatments for Metastatic Castration-sensitive Prostate Cancer in European Countries
|
Caffo, Orazio
|
|
|
4 |
6 |
p. 1011-1012
|
article
|
| 10 |
Fast Magnetic Resonance Imaging as a Viable Method for Directing the Prostate Cancer Diagnostic Pathway
|
Padhani, Anwar R.
|
|
|
4 |
6 |
p. 863-865
|
article
|
| 11 |
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing
|
Truong, Hong
|
|
|
4 |
6 |
p. 993-1000
|
article
|
| 12 |
Immune Checkpoint Inhibitors in Front-line Therapy for Urothelial Cancer
|
Szabados, Bernadett
|
|
|
4 |
6 |
p. 943-947
|
article
|
| 13 |
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)
|
Staffurth, John N.
|
|
|
4 |
6 |
p. 980-992
|
article
|
| 14 |
Magnetic Resonance Imaging/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging/Ultrasound Fusion-guided Transrectal Prostate Biopsy—A Systematic Review
|
Rai, Bhavan Prasad
|
|
|
4 |
6 |
p. 904-913
|
article
|
| 15 |
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?
|
Pederzoli, Filippo
|
|
|
4 |
6 |
p. 1006-1010
|
article
|
| 16 |
Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)
|
Crumbaker, Megan
|
|
|
4 |
6 |
p. 963-970
|
article
|
| 17 |
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial
|
Bitting, Rhonda L.
|
|
|
4 |
6 |
p. 948-954
|
article
|
| 18 |
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy
|
Panebianco, Valeria
|
|
|
4 |
6 |
p. 868-876
|
article
|
| 19 |
Reply to Anwar R. Padhani, Ivo G. Schoots, Jelle O. Barentsz. Fast Magnetic Resonance Imaging as a Viable Method for Directing the Prostate Cancer Diagnostic Pathway. Eur Urol Oncol 2021;4:863–5
|
Russo, Filippo
|
|
|
4 |
6 |
p. 866-867
|
article
|
| 20 |
Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy
|
Weiner, Adam B.
|
|
|
4 |
6 |
p. 955-962
|
article
|
| 21 |
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review
|
Van der Eecken, Kim
|
|
|
4 |
6 |
p. 914-923
|
article
|
| 22 |
Towards Biologically Driven Decision-making in Metastatic Hormone-sensitive Prostate Cancer
|
Beltran, Himisha
|
|
|
4 |
6 |
p. 924-926
|
article
|
Journal description